NASDAQ · Medical - Devices

ProSomnus, Inc. (OSA) Stock

$0.47 +0.00% NASDAQ: OSA Healthcare

ProSomnus, Inc. develops and provides specialized oral appliance therapy solutions crafted to alleviate obstructive sleep apnea (OSA).

Valuation

MetricValue
Price$0.47
Market Cap$8.18M
P/E Ratio-0.32
P/B Ratio-0.29
P/S Ratio0.30
EPS (TTM)$-1.49
52-Week High$0.50
52-Week Low$0.47
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE102.32%
ROA-91.66%
ROCE-159.94%
Gross Margin50.67%
Operating Margin-69.09%
Net Margin-87.14%
Debt/Equity-1.56
Current Ratio1.00

Annual Financials (USD)

Metric2020202120222023
Revenue$8.0M$14.0M$19.0M$28.0M
Operating Profit$-4.0M$-5.0M$-1.0M$-19.0M
Net Profit$-6.0M$-6.0M$3.0M$-24.0M
EPS$-0.38$-1.51$0.33$-1.49
Op Margin-50.1%-34.2%-5.3%-69.1%

Balance Sheet (USD)

Metric2020202120222023
Total Assets$6.0M$8.0M$33.0M$26.0M
Total Liabilities$54.0M$61.0M$54.0M$53.0M
Cash$2.0M$2.0M$16.0M$7.0M
Borrowings$10.0M$14.0M$33.0M$41.0M

Latest News

HelloNation Article Explains Invisalign Attachments With Insights From Orthodontist Dr. Ben Thornton PR Newswire · Jul 16, 2026 The US sanctioned 4 of Iran's central bank crypto wallets. Here's why. Yahoo Finance Video · Jul 16, 2026 InventHelp Inventor Develops Police Gun Holster Accessory (TKA-469) PR Newswire · Jul 16, 2026 United Airlines' Outlook Reflects Confidence in H2 Revenue per Available Seat Mile, UBS Says MT Newswires · Jul 16, 2026 Update: US Equity Indexes Mixed as Slumping Technology Pushes Nasdaq, S&P 500 Lower MT Newswires · Jul 16, 2026

Cash Flow (USD)

Metric2020202120222023
Operating Cash Flow$-4.0M$-5.0M$-10.0M$-16.0M
Investing Cash Flow$0$-1.0M$-3.0M$-3.0M
Financing Cash Flow$0$0$-8.0M$0
Net Cash Flow$1.0M$0$14.0M$-9.0M
Free Cash Flow$-4.0M$-5.0M$-12.0M$-18.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-2.40
FCF Yield-215.21%
Quick Ratio0.86
Interest Coverage-2.43
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIORBiora Therapeutics, Inc. $0.22 +0.00% 0.00 $994994 0.00%
CNTGCentogene N.V. $0.33 +100.00% -0.22 $9.42M 0.00%
CSCICOSCIENS Biopharma Inc. $2.72 +0.00% -0.35 $8.57M 0.00%
NLTXNeoleukin Therapeutics, Inc. $3.49 +1.45% -11.26 $8.20M 0.00%
NURONeuroMetrix, Inc. $4.58 +5.05% -1.16 $9.43M 0.00%

About ProSomnus, Inc.

ProSomnus, Inc. develops and provides specialized oral appliance therapy solutions crafted to alleviate obstructive sleep apnea (OSA). This enterprise, which originated in 2016, maintains its headquarters in Pleasanton, California.

ProSomnus, Inc. is headquartered in US.

ProSomnus, Inc. (OSA) stock trades at $0.47 with a market capitalization of $8.18M. The stock is valued at a price-to-earnings (P/E) ratio of -0.32, price-to-book of -0.29, price-to-sales of 0.30. Over the past 52 weeks the stock has ranged between $0.47 and $0.50, and currently trades 6.0% below its 52-week high.

On profitability, ProSomnus, Inc. generates a return on equity (ROE) of 102.32% — well above the market average, a sign of a high-quality business, return on capital employed of -159.94%, an operating margin of -69.09%, a net profit margin of -87.14%.

Official website: www.ProSomnus.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides